Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 133 to 144 of 144 entries
Sorted by: Best Match Show Resources per page
Signal Intensity of Superb Microvascular Imaging Correlates with the Severity of Acute Cholecystitis.

Case reports in gastroenterology

Tomizawa M, Shinozaki F, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N.
PMID: 27721732
Case Rep Gastroenterol. 2016 Aug 31;10(2):452-458. doi: 10.1159/000446765. eCollection 2016.

Evaluation of the severity of acute cholecystitis is critical for the management of this condition. Superb microvascular imaging (SMI) enables the assessment of slow blood flow of small vessels without any contrast medium. An 84-year-old man visited our hospital...

Cite
Tomizawa M, Shinozaki F, Motoyoshi Y, et al. Signal Intensity of Superb Microvascular Imaging Correlates with the Severity of Acute Cholecystitis. Case Rep Gastroenterol. 2016;10(2):452-458doi: 10.1159/000446765.
Tomizawa, M., Shinozaki, F., Motoyoshi, Y., Sugiyama, T., Yamamoto, S., & Ishige, N. (2016). Signal Intensity of Superb Microvascular Imaging Correlates with the Severity of Acute Cholecystitis. Case reports in gastroenterology, 10(2), 452-458. https://doi.org/10.1159/000446765
Tomizawa, Minoru, et al. "Signal Intensity of Superb Microvascular Imaging Correlates with the Severity of Acute Cholecystitis." Case reports in gastroenterology vol. 10,2 (2016): 452-458. doi: https://doi.org/10.1159/000446765
Tomizawa M, Shinozaki F, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N. Signal Intensity of Superb Microvascular Imaging Correlates with the Severity of Acute Cholecystitis. Case Rep Gastroenterol. 2016 Aug 31;10(2):452-458. doi: 10.1159/000446765. eCollection 2016. PMID: 27721732; PMCID: PMC5043169.
Copy Download .nbib Format: NLM
Comparison of DWIBS/T2 image fusion and PET/CT for the diagnosis of cancer in the abdominal cavity.

Experimental and therapeutic medicine

Tomizawa M, Shinozaki F, Uchida Y, Uchiyama K, Tanaka S, Sunaoshi T, Kano D, Sugiyama E, Shite M, Haga R, Fukamizu Y, Fujita T, Kagayama S, Hasegawa R, Shirai Y, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N.
PMID: 29042975
Exp Ther Med. 2017 Oct;14(4):3754-3760. doi: 10.3892/etm.2017.4987. Epub 2017 Aug 22.

Fusion images of diffusion-weighted whole-body imaging with background body signal suppression and T2-weighted image (DWIBS/T2) demonstrate a strong signal for malignancies, with a high contrast against the surrounding tissues, and enable anatomical analysis. In the present study, DWIBS/T2 was...

Cite
Tomizawa M, Shinozaki F, Uchida Y, et al. Comparison of DWIBS/T2 image fusion and PET/CT for the diagnosis of cancer in the abdominal cavity. Exp Ther Med. 2017;14(4):3754-3760doi: 10.3892/etm.2017.4987.
Tomizawa, M., Shinozaki, F., Uchida, Y., Uchiyama, K., Tanaka, S., Sunaoshi, T., Kano, D., Sugiyama, E., Shite, M., Haga, R., Fukamizu, Y., Fujita, T., Kagayama, S., Hasegawa, R., Shirai, Y., Motoyoshi, Y., Sugiyama, T., Yamamoto, S., & Ishige, N. (2017). Comparison of DWIBS/T2 image fusion and PET/CT for the diagnosis of cancer in the abdominal cavity. Experimental and therapeutic medicine, 14(4), 3754-3760. https://doi.org/10.3892/etm.2017.4987
Tomizawa, Minoru, et al. "Comparison of DWIBS/T2 image fusion and PET/CT for the diagnosis of cancer in the abdominal cavity." Experimental and therapeutic medicine vol. 14,4 (2017): 3754-3760. doi: https://doi.org/10.3892/etm.2017.4987
Tomizawa M, Shinozaki F, Uchida Y, Uchiyama K, Tanaka S, Sunaoshi T, Kano D, Sugiyama E, Shite M, Haga R, Fukamizu Y, Fujita T, Kagayama S, Hasegawa R, Shirai Y, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N. Comparison of DWIBS/T2 image fusion and PET/CT for the diagnosis of cancer in the abdominal cavity. Exp Ther Med. 2017 Oct;14(4):3754-3760. doi: 10.3892/etm.2017.4987. Epub 2017 Aug 22. PMID: 29042975; PMCID: PMC5639341.
Copy Download .nbib Format: NLM
Subacute pneumothorax contralateral to the venous access site associated with atrial lead perforation in a patient who was receiving corticosteroid therapy.

Journal of arrhythmia

Ishizue N, Kishihara J, Niwano S, Ako J.
PMID: 28765768
J Arrhythm. 2017 Aug;33(4):335-337. doi: 10.1016/j.joa.2017.03.003. Epub 2017 May 04.

Pneumothorax contralateral to the venous access site due to the right atrial lead is an uncommon complication. Concomitant steroid use is known as a risk factor of pacemaker lead perforation. We report a rare case of subacute contralateral pneumothorax...

Cite
Ishizue N, Kishihara J, Niwano S, et al. Subacute pneumothorax contralateral to the venous access site associated with atrial lead perforation in a patient who was receiving corticosteroid therapy. J Arrhythm. 2017;33(4):335-337doi: 10.1016/j.joa.2017.03.003.
Ishizue, N., Kishihara, J., Niwano, S., & Ako, J. (2017). Subacute pneumothorax contralateral to the venous access site associated with atrial lead perforation in a patient who was receiving corticosteroid therapy. Journal of arrhythmia, 33(4), 335-337. https://doi.org/10.1016/j.joa.2017.03.003
Ishizue, Naruya, et al. "Subacute pneumothorax contralateral to the venous access site associated with atrial lead perforation in a patient who was receiving corticosteroid therapy." Journal of arrhythmia vol. 33,4 (2017): 335-337. doi: https://doi.org/10.1016/j.joa.2017.03.003
Ishizue N, Kishihara J, Niwano S, Ako J. Subacute pneumothorax contralateral to the venous access site associated with atrial lead perforation in a patient who was receiving corticosteroid therapy. J Arrhythm. 2017 Aug;33(4):335-337. doi: 10.1016/j.joa.2017.03.003. Epub 2017 May 04. PMID: 28765768; PMCID: PMC5529589.
Copy Download .nbib Format: NLM
Hepatocyte selection medium eliminating induced pluripotent stem cells among primary human hepatocytes.

World journal of methodology

Tomizawa M, Shinozaki F, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N.
PMID: 26413482
World J Methodol. 2015 Sep 26;5(3):108-14. doi: 10.5662/wjm.v5.i3.108. eCollection 2015 Sep 26.

Hepatic insufficiency is a fatal liver disease with a significant decrease in functioning hepatocytes. If hepatocytes could be generated from human induced pluripotent stem (hiPS) cells and transplanted into patients with hepatic insufficiency, the disease may become curable. However,...

Cite
Tomizawa M, Shinozaki F, Motoyoshi Y, et al. Hepatocyte selection medium eliminating induced pluripotent stem cells among primary human hepatocytes. World J Methodol. 2015;5(3):108-14doi: 10.5662/wjm.v5.i3.108.
Tomizawa, M., Shinozaki, F., Motoyoshi, Y., Sugiyama, T., Yamamoto, S., & Ishige, N. (2015). Hepatocyte selection medium eliminating induced pluripotent stem cells among primary human hepatocytes. World journal of methodology, 5(3), 108-14. https://doi.org/10.5662/wjm.v5.i3.108
Tomizawa, Minoru, et al. "Hepatocyte selection medium eliminating induced pluripotent stem cells among primary human hepatocytes." World journal of methodology vol. 5,3 (2015): 108-14. doi: https://doi.org/10.5662/wjm.v5.i3.108
Tomizawa M, Shinozaki F, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N. Hepatocyte selection medium eliminating induced pluripotent stem cells among primary human hepatocytes. World J Methodol. 2015 Sep 26;5(3):108-14. doi: 10.5662/wjm.v5.i3.108. eCollection 2015 Sep 26. PMID: 26413482; PMCID: PMC4572022.
Copy Download .nbib Format: NLM
Oct3/4 is potentially useful for the suppression of the proliferation and motility of hepatocellular carcinoma cells.

Oncology letters

Tomizawa M, Shinozaki F, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N.
PMID: 30250594
Oncol Lett. 2018 Oct;16(4):5243-5248. doi: 10.3892/ol.2018.9292. Epub 2018 Aug 10.

Hepatocellular carcinoma (HCC) cells are immature compared with healthy mature hepatocytes. Transcription factors serve a role in hepatocyte differentiation. The expression levels of transcription factors in HCC cell lines have been investigated to determine potential therapeutic targets. In the...

Cite
Tomizawa M, Shinozaki F, Motoyoshi Y, et al. Oct3/4 is potentially useful for the suppression of the proliferation and motility of hepatocellular carcinoma cells. Oncol Lett. 2018;16(4):5243-5248doi: 10.3892/ol.2018.9292.
Tomizawa, M., Shinozaki, F., Motoyoshi, Y., Sugiyama, T., Yamamoto, S., & Ishige, N. (2018). Oct3/4 is potentially useful for the suppression of the proliferation and motility of hepatocellular carcinoma cells. Oncology letters, 16(4), 5243-5248. https://doi.org/10.3892/ol.2018.9292
Tomizawa, Minoru, et al. "Oct3/4 is potentially useful for the suppression of the proliferation and motility of hepatocellular carcinoma cells." Oncology letters vol. 16,4 (2018): 5243-5248. doi: https://doi.org/10.3892/ol.2018.9292
Tomizawa M, Shinozaki F, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N. Oct3/4 is potentially useful for the suppression of the proliferation and motility of hepatocellular carcinoma cells. Oncol Lett. 2018 Oct;16(4):5243-5248. doi: 10.3892/ol.2018.9292. Epub 2018 Aug 10. PMID: 30250594; PMCID: PMC6144932.
Copy Download .nbib Format: NLM
Energy loss by right ventricular pacing: Patients with versus without hypertrophic cardiomyopathy.

Journal of arrhythmia

Arakawa Y, Fukaya H, Kakizaki R, Oikawa J, Saito D, Sato T, Matsuura G, Kobayashi S, Shirakawa Y, Nishinarita R, Horiguchi A, Ishizue N, Nabeta T, Kishihara J, Niwano S, Ako J.
PMID: 33664904
J Arrhythm. 2020 Dec 06;37(1):203-211. doi: 10.1002/joa3.12472. eCollection 2021 Feb.

BACKGROUND: Right ventricular (RV) pacing causes left ventricular (LV) dyssynchrony sometimes resulting in pacing-induced cardiomyopathy. However, RV pacing for hypertrophic obstructive cardiomyopathy is one of the treatment options. LV flow energy loss (EL) using vector flow mapping (VFM) is...

Cite
Arakawa Y, Fukaya H, Kakizaki R, et al. Energy loss by right ventricular pacing: Patients with versus without hypertrophic cardiomyopathy. J Arrhythm. 2020;37(1):203-211doi: 10.1002/joa3.12472.
Arakawa, Y., Fukaya, H., Kakizaki, R., Oikawa, J., Saito, D., Sato, T., Matsuura, G., Kobayashi, S., Shirakawa, Y., Nishinarita, R., Horiguchi, A., Ishizue, N., Nabeta, T., Kishihara, J., Niwano, S., & Ako, J. (2021). Energy loss by right ventricular pacing: Patients with versus without hypertrophic cardiomyopathy. Journal of arrhythmia, 37(1), 203-211. https://doi.org/10.1002/joa3.12472
Arakawa, Yuki, et al. "Energy loss by right ventricular pacing: Patients with versus without hypertrophic cardiomyopathy." Journal of arrhythmia vol. 37,1 (2021): 203-211. doi: https://doi.org/10.1002/joa3.12472
Arakawa Y, Fukaya H, Kakizaki R, Oikawa J, Saito D, Sato T, Matsuura G, Kobayashi S, Shirakawa Y, Nishinarita R, Horiguchi A, Ishizue N, Nabeta T, Kishihara J, Niwano S, Ako J. Energy loss by right ventricular pacing: Patients with versus without hypertrophic cardiomyopathy. J Arrhythm. 2020 Dec 06;37(1):203-211. doi: 10.1002/joa3.12472. eCollection 2021 Feb. PMID: 33664904; PMCID: PMC7896474.
Copy Download .nbib Format: NLM
Development of Second-Tier Liquid Chromatography-Tandem Mass Spectrometry Analysis for Expanded Newborn Screening in Japan.

International journal of neonatal screening

Shigematsu Y, Yuasa M, Ishige N, Nakajima H, Tajima G.
PMID: 34287228
Int J Neonatal Screen. 2021 Jul 14;7(3). doi: 10.3390/ijns7030044.

To minimize false-positive cases in newborn screening by tandem mass spectrometry in Japan, practical second-tier liquid chromatography-tandem mass spectrometry analyses have been developed using a multimode ODS column with a single set of mobile phases and different gradient elution...

Cite
Shigematsu Y, Yuasa M, Ishige N, et al. Development of Second-Tier Liquid Chromatography-Tandem Mass Spectrometry Analysis for Expanded Newborn Screening in Japan. Int J Neonatal Screen. 2021;7(3)doi: 10.3390/ijns7030044.
Shigematsu, Y., Yuasa, M., Ishige, N., Nakajima, H., & Tajima, G. (2021). Development of Second-Tier Liquid Chromatography-Tandem Mass Spectrometry Analysis for Expanded Newborn Screening in Japan. International journal of neonatal screening, 7(3), . https://doi.org/10.3390/ijns7030044
Shigematsu, Yosuke, et al. "Development of Second-Tier Liquid Chromatography-Tandem Mass Spectrometry Analysis for Expanded Newborn Screening in Japan." International journal of neonatal screening vol. 7,3 (2021). doi: https://doi.org/10.3390/ijns7030044
Shigematsu Y, Yuasa M, Ishige N, Nakajima H, Tajima G. Development of Second-Tier Liquid Chromatography-Tandem Mass Spectrometry Analysis for Expanded Newborn Screening in Japan. Int J Neonatal Screen. 2021 Jul 14;7(3). doi: 10.3390/ijns7030044. PMID: 34287228; PMCID: PMC8293176.
Copy Download .nbib Format: NLM
Salt Sensitivity of Blood Pressure in Blacks and Women: A Role of Inflammation, Oxidative Stress, and Epithelial Na.

Antioxidants & redox signaling

Sahinoz M, Elijovich F, Ertuglu LA, Ishimwe J, Pitzer A, Saleem M, Mwesigwa N, Kleyman TR, Laffer CL, Kirabo A.
PMID: 34569287
Antioxid Redox Signal. 2021 Dec 20;35(18):1477-1493. doi: 10.1089/ars.2021.0212.

No abstract available.

Cite
Sahinoz M, Elijovich F, Ertuglu LA, et al. Salt Sensitivity of Blood Pressure in Blacks and Women: A Role of Inflammation, Oxidative Stress, and Epithelial Na. Antioxid Redox Signal. 2021;35(18):1477-1493doi: 10.1089/ars.2021.0212.
Sahinoz, M., Elijovich, F., Ertuglu, L. A., Ishimwe, J., Pitzer, A., Saleem, M., Mwesigwa, N., Kleyman, T. R., Laffer, C. L., & Kirabo, A. (2021). Salt Sensitivity of Blood Pressure in Blacks and Women: A Role of Inflammation, Oxidative Stress, and Epithelial Na. Antioxidants & redox signaling, 35(18), 1477-1493. https://doi.org/10.1089/ars.2021.0212
Sahinoz, Melis, et al. "Salt Sensitivity of Blood Pressure in Blacks and Women: A Role of Inflammation, Oxidative Stress, and Epithelial Na." Antioxidants & redox signaling vol. 35,18 (2021): 1477-1493. doi: https://doi.org/10.1089/ars.2021.0212
Sahinoz M, Elijovich F, Ertuglu LA, Ishimwe J, Pitzer A, Saleem M, Mwesigwa N, Kleyman TR, Laffer CL, Kirabo A. Salt Sensitivity of Blood Pressure in Blacks and Women: A Role of Inflammation, Oxidative Stress, and Epithelial Na. Antioxid Redox Signal. 2021 Dec 20;35(18):1477-1493. doi: 10.1089/ars.2021.0212. PMID: 34569287.
Copy Download .nbib Format: NLM
Clinical and microbiological outcomes, by causative pathogen, in the ASPECT-NP randomized, controlled, Phase 3 trial comparing ceftolozane/tazobactam and meropenem for treatment of hospital-acquired/ventilator-associated bacterial pneumonia.

The Journal of antimicrobial chemotherapy

Martin-Loeches I, Timsit JF, Kollef MH, Wunderink RG, Shime N, Nováček M, Kivistik Ü, Réa-Neto Á, Bruno CJ, Huntington JA, Lin G, Jensen EH, Motyl M, Yu B, Gates D, Butterton JR, Rhee EG, Jin H, Guo C, Liu J, Vasileff A, Jiao Y.
PMID: 35022730
J Antimicrob Chemother. 2022 Jan 12; doi: 10.1093/jac/dkab494. Epub 2022 Jan 12.

OBJECTIVES: In the ASPECT-NP trial, ceftolozane/tazobactam was non-inferior to meropenem for treating nosocomial pneumonia; efficacy outcomes by causative pathogen were to be evaluated.METHODS: Mechanically ventilated participants with hospital-acquired/ventilator-associated bacterial pneumonia were randomized to 3 g ceftolozane/tazobactam (2 g ceftolozane/1...

Cite
Martin-Loeches I, Timsit JF, Kollef MH, et al. Clinical and microbiological outcomes, by causative pathogen, in the ASPECT-NP randomized, controlled, Phase 3 trial comparing ceftolozane/tazobactam and meropenem for treatment of hospital-acquired/ventilator-associated bacterial pneumonia. J Antimicrob Chemother. 2022;doi: 10.1093/jac/dkab494.
Martin-Loeches, I., Timsit, J. F., Kollef, M. H., Wunderink, R. G., Shime, N., Nováček, M., Kivistik, �. �., Réa-Neto, �. �., Bruno, C. J., Huntington, J. A., Lin, G., Jensen, E. H., Motyl, M., Yu, B., Gates, D., Butterton, J. R., Rhee, E. G., Jin, H., Guo, C., Liu, J., Vasileff, A., & Jiao, Y. (2022). Clinical and microbiological outcomes, by causative pathogen, in the ASPECT-NP randomized, controlled, Phase 3 trial comparing ceftolozane/tazobactam and meropenem for treatment of hospital-acquired/ventilator-associated bacterial pneumonia. The Journal of antimicrobial chemotherapy, . https://doi.org/10.1093/jac/dkab494
Martin-Loeches, Ignacio, et al. "Clinical and microbiological outcomes, by causative pathogen, in the ASPECT-NP randomized, controlled, Phase 3 trial comparing ceftolozane/tazobactam and meropenem for treatment of hospital-acquired/ventilator-associated bacterial pneumonia." The Journal of antimicrobial chemotherapy vol. (2022). doi: https://doi.org/10.1093/jac/dkab494
Martin-Loeches I, Timsit JF, Kollef MH, Wunderink RG, Shime N, Nováček M, Kivistik Ü, Réa-Neto Á, Bruno CJ, Huntington JA, Lin G, Jensen EH, Motyl M, Yu B, Gates D, Butterton JR, Rhee EG, Jin H, Guo C, Liu J, Vasileff A, Jiao Y. Clinical and microbiological outcomes, by causative pathogen, in the ASPECT-NP randomized, controlled, Phase 3 trial comparing ceftolozane/tazobactam and meropenem for treatment of hospital-acquired/ventilator-associated bacterial pneumonia. J Antimicrob Chemother. 2022 Jan 12; doi: 10.1093/jac/dkab494. Epub 2022 Jan 12. PMID: 35022730.
Copy Download .nbib Format: NLM
Hypertension: Do Inflammation and Immunity Hold the Key to Solving this Epidemic?.

Circulation research

Madhur MS, Elijovich F, Alexander MR, Pitzer A, Ishimwe J, Van Beusecum JP, Patrick DM, Smart CD, Kleyman TR, Kingery J, Peck RN, Laffer CL, Kirabo A.
PMID: 33793336
Circ Res. 2021 Apr 02;128(7):908-933. doi: 10.1161/CIRCRESAHA.121.318052. Epub 2021 Apr 01.

Elevated cardiovascular risk including stroke, heart failure, and heart attack is present even after normalization of blood pressure in patients with hypertension. Underlying immune cell activation is a likely culprit. Although immune cells are important for protection against invading...

Cite
Madhur MS, Elijovich F, Alexander MR, et al. Hypertension: Do Inflammation and Immunity Hold the Key to Solving this Epidemic?. Circ Res. 2021;128(7):908-933doi: 10.1161/CIRCRESAHA.121.318052.
Madhur, M. S., Elijovich, F., Alexander, M. R., Pitzer, A., Ishimwe, J., Van Beusecum, J. P., Patrick, D. M., Smart, C. D., Kleyman, T. R., Kingery, J., Peck, R. N., Laffer, C. L., & Kirabo, A. (2021). Hypertension: Do Inflammation and Immunity Hold the Key to Solving this Epidemic?. Circulation research, 128(7), 908-933. https://doi.org/10.1161/CIRCRESAHA.121.318052
Madhur, Meena S, et al. "Hypertension: Do Inflammation and Immunity Hold the Key to Solving this Epidemic?." Circulation research vol. 128,7 (2021): 908-933. doi: https://doi.org/10.1161/CIRCRESAHA.121.318052
Madhur MS, Elijovich F, Alexander MR, Pitzer A, Ishimwe J, Van Beusecum JP, Patrick DM, Smart CD, Kleyman TR, Kingery J, Peck RN, Laffer CL, Kirabo A. Hypertension: Do Inflammation and Immunity Hold the Key to Solving this Epidemic?. Circ Res. 2021 Apr 02;128(7):908-933. doi: 10.1161/CIRCRESAHA.121.318052. Epub 2021 Apr 01. PMID: 33793336; PMCID: PMC8023750.
Copy Download .nbib Format: NLM
Hypertension: Do Inflammation and Immunity Hold the Key to Solving this Epidemic?.

Circulation research

Madhur MS, Elijovich F, Alexander MR, Pitzer A, Ishimwe J, Van Beusecum JP, Patrick DM, Smart CD, Kleyman TR, Kingery J, Peck RN, Laffer CL, Kirabo A.
PMID: 33793336
Circ Res. 2021 Apr 02;128(7):908-933. doi: 10.1161/CIRCRESAHA.121.318052. Epub 2021 Apr 01.

Elevated cardiovascular risk including stroke, heart failure, and heart attack is present even after normalization of blood pressure in patients with hypertension. Underlying immune cell activation is a likely culprit. Although immune cells are important for protection against invading...

Cite
Madhur MS, Elijovich F, Alexander MR, et al. Hypertension: Do Inflammation and Immunity Hold the Key to Solving this Epidemic?. Circ Res. 2021;128(7):908-933doi: 10.1161/CIRCRESAHA.121.318052.
Madhur, M. S., Elijovich, F., Alexander, M. R., Pitzer, A., Ishimwe, J., Van Beusecum, J. P., Patrick, D. M., Smart, C. D., Kleyman, T. R., Kingery, J., Peck, R. N., Laffer, C. L., & Kirabo, A. (2021). Hypertension: Do Inflammation and Immunity Hold the Key to Solving this Epidemic?. Circulation research, 128(7), 908-933. https://doi.org/10.1161/CIRCRESAHA.121.318052
Madhur, Meena S, et al. "Hypertension: Do Inflammation and Immunity Hold the Key to Solving this Epidemic?." Circulation research vol. 128,7 (2021): 908-933. doi: https://doi.org/10.1161/CIRCRESAHA.121.318052
Madhur MS, Elijovich F, Alexander MR, Pitzer A, Ishimwe J, Van Beusecum JP, Patrick DM, Smart CD, Kleyman TR, Kingery J, Peck RN, Laffer CL, Kirabo A. Hypertension: Do Inflammation and Immunity Hold the Key to Solving this Epidemic?. Circ Res. 2021 Apr 02;128(7):908-933. doi: 10.1161/CIRCRESAHA.121.318052. Epub 2021 Apr 01. PMID: 33793336; PMCID: PMC8023750.
Copy Download .nbib Format: NLM
Reduced atrial conduction velocity is associated with the recurrence of atrial fibrillation after catheter ablation.

Heart and vessels

Sato T, Fukaya H, Oikawa J, Saito D, Matsuura G, Arakawa Y, Kobayashi S, Shirakawa Y, Nishinarita R, Horiguchi A, Ishizue N, Kishihara J, Niwano S, Ako J.
PMID: 34613425
Heart Vessels. 2021 Oct 06; doi: 10.1007/s00380-021-01952-6. Epub 2021 Oct 06.

The recurrence of atrial fibrillation (AF) after catheter ablation (CA) is still an unsolved issue. Although structural remodeling is relatively well defined, the method to assess electrical remodeling of the atrium is not well established. In this study, we...

Cite
Sato T, Fukaya H, Oikawa J, et al. Reduced atrial conduction velocity is associated with the recurrence of atrial fibrillation after catheter ablation. Heart Vessels. 2021;doi: 10.1007/s00380-021-01952-6.
Sato, T., Fukaya, H., Oikawa, J., Saito, D., Matsuura, G., Arakawa, Y., Kobayashi, S., Shirakawa, Y., Nishinarita, R., Horiguchi, A., Ishizue, N., Kishihara, J., Niwano, S., & Ako, J. (2021). Reduced atrial conduction velocity is associated with the recurrence of atrial fibrillation after catheter ablation. Heart and vessels, . https://doi.org/10.1007/s00380-021-01952-6
Sato, Tetsuro, et al. "Reduced atrial conduction velocity is associated with the recurrence of atrial fibrillation after catheter ablation." Heart and vessels vol. (2021). doi: https://doi.org/10.1007/s00380-021-01952-6
Sato T, Fukaya H, Oikawa J, Saito D, Matsuura G, Arakawa Y, Kobayashi S, Shirakawa Y, Nishinarita R, Horiguchi A, Ishizue N, Kishihara J, Niwano S, Ako J. Reduced atrial conduction velocity is associated with the recurrence of atrial fibrillation after catheter ablation. Heart Vessels. 2021 Oct 06; doi: 10.1007/s00380-021-01952-6. Epub 2021 Oct 06. PMID: 34613425.
Copy Download .nbib Format: NLM
Showing 133 to 144 of 144 entries